CPT® Code 83586

1. Indications

The 17-ketosteroid (17-KS) test is indicated for the evaluation of various clinical conditions related to adrenal hormone production and metabolism. The following conditions may warrant the performance of this test:

• Adrenal Hyperplasia This condition can lead to elevated levels of 17-KS, particularly in cases associated with precocious puberty.
• Cushing Syndrome Elevated 17-KS levels may be observed in patients suffering from this disorder, which is characterized by excessive cortisol production.
• Obesity The test may be utilized to assess hormonal imbalances that could contribute to obesity.
• Pathological Stress Conditions Situations such as acute illness, infection, surgery, and burns can lead to increased levels of 17-KS, indicating a stress response from the adrenal glands.
• Addison's Disease In this condition, decreased levels of 17-KS may be indicative of adrenal insufficiency.
• ACTH Deficiency A lack of adrenocorticotropic hormone can result in lower levels of 17-KS, suggesting a disruption in adrenal function.
• Hypopituitarism This condition may also lead to decreased production of adrenal hormones, reflected in lower 17-KS levels.

2. Procedure

The procedure for measuring total 17-ketosteroids in urine involves several key steps to ensure accurate results. The first step is the collection of a 24-hour urine sample from the patient. This comprehensive collection period is crucial as it allows for the measurement of hormone levels over an entire day, providing a more accurate representation of the patient's adrenal function. Once the sample is collected, it is sent to a laboratory where it undergoes quantitative spectrophotometry analysis. This analytical technique measures the concentration of 17-KS in the urine by detecting the specific wavelengths of light absorbed by the steroid compounds. The results are then compiled and interpreted by healthcare professionals to assess the patient's adrenal hormone levels and identify any potential endocrine disorders.

3. Post-Procedure

After the 24-hour urine collection and subsequent analysis, patients may not require any specific post-procedure care, as the test is non-invasive and does not involve any physical intervention. However, it is essential for healthcare providers to discuss the results with the patient, as elevated or decreased levels of 17-KS can indicate underlying health issues that may require further investigation or treatment. Patients should be informed about the significance of their results and any necessary follow-up actions, including additional testing or referrals to specialists if indicated.